The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

This cohort study investigates the association between low levels of ERBB2 expression and progression-free survival among patients with HR+/ERBB2− metastatic breast cancer treated with CDK4/6 inhibitors.

Detalles Bibliográficos
Autores principales: Bao, Kelvin K. H., Sutanto, Leone, Tse, Shirley S. W., Man Cheung, Ka, Chan, Jeffrey C. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571658/
https://www.ncbi.nlm.nih.gov/pubmed/34739066
http://dx.doi.org/10.1001/jamanetworkopen.2021.33132
_version_ 1784595070761041920
author Bao, Kelvin K. H.
Sutanto, Leone
Tse, Shirley S. W.
Man Cheung, Ka
Chan, Jeffrey C. H.
author_facet Bao, Kelvin K. H.
Sutanto, Leone
Tse, Shirley S. W.
Man Cheung, Ka
Chan, Jeffrey C. H.
author_sort Bao, Kelvin K. H.
collection PubMed
description This cohort study investigates the association between low levels of ERBB2 expression and progression-free survival among patients with HR+/ERBB2− metastatic breast cancer treated with CDK4/6 inhibitors.
format Online
Article
Text
id pubmed-8571658
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-85716582021-11-17 The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer Bao, Kelvin K. H. Sutanto, Leone Tse, Shirley S. W. Man Cheung, Ka Chan, Jeffrey C. H. JAMA Netw Open Research Letter This cohort study investigates the association between low levels of ERBB2 expression and progression-free survival among patients with HR+/ERBB2− metastatic breast cancer treated with CDK4/6 inhibitors. American Medical Association 2021-11-05 /pmc/articles/PMC8571658/ /pubmed/34739066 http://dx.doi.org/10.1001/jamanetworkopen.2021.33132 Text en Copyright 2021 Bao KKH et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Bao, Kelvin K. H.
Sutanto, Leone
Tse, Shirley S. W.
Man Cheung, Ka
Chan, Jeffrey C. H.
The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
title The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
title_full The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
title_fullStr The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
title_full_unstemmed The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
title_short The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
title_sort association of erbb2-low expression with the efficacy of cyclin-dependent kinase 4/6 inhibitor in hormone receptor–positive, erbb2-negative metastatic breast cancer
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571658/
https://www.ncbi.nlm.nih.gov/pubmed/34739066
http://dx.doi.org/10.1001/jamanetworkopen.2021.33132
work_keys_str_mv AT baokelvinkh theassociationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT sutantoleone theassociationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT tseshirleysw theassociationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT mancheungka theassociationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT chanjeffreych theassociationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT baokelvinkh associationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT sutantoleone associationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT tseshirleysw associationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT mancheungka associationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer
AT chanjeffreych associationoferbb2lowexpressionwiththeefficacyofcyclindependentkinase46inhibitorinhormonereceptorpositiveerbb2negativemetastaticbreastcancer

Ejemplares similares